Micheletti Tatiane, Brown Janine L, Walker Susan L, Cubas Zalmir S, Furtado Priscila V, Putman Sarah B, de Moraes Wanderlei, de Oliveira Marcos J, de Oliveira Claudio A, Moreira Nei
Federal University of Parana, Department of Veterinary Medicine and Animal Science, Palotina, Paraná, Brazil; Brazilian Institute for Conservation Medicine - TRÍADE, Curitiba, Brazil.
Smithsonian Conservation Biology Institute, Front Royal, Virginia, USA.
Theriogenology. 2015 Sep 1;84(4):575-82. doi: 10.1016/j.theriogenology.2015.04.015. Epub 2015 Apr 28.
The goal of this study was to optimize an ovulation induction protocol for use with artificial insemination in the southern tigrina (Leopardus guttulus). The specific aims were to report the efficacy of using altrenogest, an oral progestin (Regumate, MSD Animal Health, Merck Animal Health), to suppress ovarian activity and prevent follicular hyperstimulation and hyperestrogenism after the administration of exogenous eCG and hCG. To monitor ovarian responses, fecal estrogen and progestogen metabolites were quantified by enzyme immunoassay in females before and after intramuscular administration of 200-IU eCG and 150-IU hCG in two trials, 4 months apart. During the first trial, there was no use of altrenogest, only the eCG-hCG ovulation induction protocol. In the second trial, the ovulation induction protocol was preceded by the administration of oral altrenogest for 14 days (minimum of 0.192 mg per kg per day). Altrenogest administration resulted in a suppression of follicular activity in three out of six females before eCG-hCG administration on the basis of lower mean estrogen concentrations (P < 0.05). It also resulted in four out of six females presenting lower fecal estrogen metabolite concentrations (P < 0.05) after ovulation induction, and two out of six individuals showed a reduction (P < 0.05) in postovulatory fecal progestogen metabolite concentrations, all when compared to the same female's cycles without the progestin. Fecal estrogen metabolite concentrations were closer to baseline in 50% of these individuals after altrenogest and eCG-hCG treatments when compared to basal concentrations before gonadotropins without the use of altrenogest. This study reported that use of altrenogest in southern tigrina can suppress ovarian activity and avoid hyperestrogenism after administration of eCG and hCG treatment. However, not all females responded uniformly, so more studies are needed to increase the efficacy of ovulation induction for use with artificial insemination in this species.
本研究的目的是优化一种排卵诱导方案,用于南方虎猫(Leopardus guttulus)的人工授精。具体目标是报告使用口服孕激素烯丙孕素(Regumate,默克动物保健公司)抑制卵巢活动,并防止在给予外源性eCG和hCG后出现卵泡过度刺激和高雌激素血症的效果。为监测卵巢反应,在两项间隔4个月的试验中,对雌性动物在肌肉注射200国际单位eCG和150国际单位hCG前后,通过酶免疫测定法对粪便中的雌激素和孕激素代谢物进行定量。在第一次试验中,未使用烯丙孕素,仅采用eCG - hCG排卵诱导方案。在第二次试验中,在排卵诱导方案之前先口服烯丙孕素14天(每天每千克最低0.192毫克)。基于较低的平均雌激素浓度(P < 0.05),在给予eCG - hCG之前,烯丙孕素给药导致六只雌性中有三只的卵泡活动受到抑制。与未使用孕激素时同一雌性的周期相比,排卵诱导后六只雌性中有四只的粪便雌激素代谢物浓度降低(P < 0.05),六只个体中有两只排卵后的粪便孕激素代谢物浓度降低(P < 0.05)。与未使用烯丙孕素的促性腺激素给药前的基础浓度相比,在这些个体中,50%在烯丙孕素和eCG - hCG治疗后的粪便雌激素代谢物浓度更接近基线。本研究报告称,在南方虎猫中使用烯丙孕素可抑制卵巢活动,并避免在给予eCG和hCG治疗后出现高雌激素血症。然而,并非所有雌性的反应都一致,因此需要更多研究来提高该物种人工授精排卵诱导的效果。